DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,090 filers reported holding DANAHER CORPORATION in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $109,000 | +159.5% | 358 | +126.6% | 0.01% | +180.0% |
Q2 2021 | $42,000 | +100.0% | 158 | +71.7% | 0.01% | +150.0% |
Q1 2021 | $21,000 | +90.9% | 92 | +84.0% | 0.00% | +100.0% |
Q4 2020 | $11,000 | +22.2% | 50 | +16.3% | 0.00% | 0.0% |
Q3 2020 | $9,000 | +350.0% | 43 | +330.0% | 0.00% | – |
Q2 2020 | $2,000 | -90.5% | 10 | -93.3% | 0.00% | -100.0% |
Q2 2019 | $21,000 | +50.0% | 150 | +12.8% | 0.00% | 0.0% |
Q4 2018 | $14,000 | 0.0% | 133 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $14,000 | +7.7% | 133 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $13,000 | -100.0% | 133 | -78.7% | 0.00% | -80.0% |
Q2 2017 | $52,744,000 | +2367.0% | 625 | +2400.0% | 0.01% | – |
Q1 2017 | $2,138,000 | +9.9% | 25 | 0.0% | 0.00% | – |
Q4 2016 | $1,946,000 | -0.7% | 25 | 0.0% | 0.00% | – |
Q3 2016 | $1,960,000 | -22.4% | 25 | 0.0% | 0.00% | -100.0% |
Q2 2016 | $2,525,000 | +4.7% | 25 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $2,411,000 | +120450.0% | 25 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $2,000 | -81.8% | 25 | -81.3% | 0.00% | -66.7% |
Q3 2015 | $11,000 | – | 134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |